Safety and cost analysis of early discharge following percutaneous coronary intervention for acute coronary syndrome in patients with diabetes mellitus

被引:0
|
作者
Li, Shihong [1 ]
Li, Zhizhong [1 ]
Hou, Xuejian [1 ]
Sun, Junping [1 ]
Kang, Lihui [1 ]
Cheng, Yutong [1 ]
Tao, Ying [1 ]
Li, Zhao [1 ]
Chen, Xuanzu [1 ]
Zhang, Donghua [1 ]
Yan, Xianliang [1 ]
Wang, Su [1 ]
Gao, Yulong [1 ]
Wang, Qian [1 ]
Lin, Yun [1 ]
Yin, Chengqian [1 ]
Zhang, Jingmei [1 ]
Gao, Yun [1 ]
Huang, Ji [1 ]
Wu, Xiangyu [1 ]
Li, Nan [1 ]
Su, Wang [1 ]
Liu, Honghong [1 ]
Sun, Tao [1 ]
机构
[1] Capital Med Univ, Beijing Zhen Hosp, Dept Cardiol, 2 Anzhen Rd, Beijing 100029, Peoples R China
关键词
Diabetes mellitus; safety and cost; acute coronary syndrome; percutaneous coronary intervention; early discharge; hospitalization; ELEVATION MYOCARDIAL-INFARCTION; ASSOCIATION TASK-FORCE; SAME-DAY DISCHARGE; LENGTH-OF-STAY; HEART-DISEASE; CARDIOVASCULAR-ANGIOGRAPHY; ARTERY-DISEASE; IMPACT; REVASCULARIZATION; METAANALYSIS;
D O I
10.1177/0300060519842777
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective To evaluate the safety and cost of early discharge compared with ordinary discharge in patients with diabetes mellitus (DM) following percutaneous coronary intervention (PCI) for acute coronary syndrome. Methods We performed a retrospective analysis of prospectively collected data from 474 patients with DM who were discharged from hospital following PCI at a regional center between 2012 and 2015. Results A total of 192 patients (40.5%) were included in the early discharge group and 282 patients (59.5%) were included in the ordinary group. Mortality and morbidity after PCI were recorded. Kaplan-Meier analysis showed similar prognosis between the two groups at 30 days and at 1 year after discharge. However, hospitalization expenses for the regular discharge group were significantly higher than those of the early discharge group (RMB65,750 vs. RMB50,983). Conclusion Our findings demonstrate that early discharge of patients with DM following PCI for acute coronary syndrome is safe compared with ordinary discharge, and may reduce hospitalization costs.
引用
收藏
页码:3905 / 3917
页数:13
相关论文
共 50 条
  • [1] Secondary prevention therapies following percutaneous coronary intervention or acute coronary syndrome in patients with diabetes mellitus
    Planchat, Arnaud
    Gencer, Baris
    Degrauwe, Sophie
    Musayeb, Yazan
    Roffi, Marco
    Iglesias, Juan F.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [2] The early percutaneous coronary intervention in elderly patients with acute coronary syndrome
    Huang X.
    Cao X.
    Zhang G.
    Frontiers of Medicine in China, 2008, 2 (1): : 15 - 18
  • [3] Safety of Early Discharge Following Percutaneous Coronary Intervention (PCI) for STEMI
    Roberts, Louise
    Parfrey, Shane
    Andrianopoulos, Nick
    Teh, Andrew
    Brennan, Angela
    Hiew, Chin
    Clark, David
    Duffy, Stephen
    Ajani, Andrew
    Reid, Chris
    Freeman, Melanie
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (18) : B76 - B77
  • [4] Serum Calprotectin Levels and Outcome Following Percutaneous Coronary Intervention in Patients with Diabetes and Acute Coronary Syndrome
    Wang, Chengji
    Kong, Yu
    Ding, Yuanyuan
    Sun, Jingzhi
    Chen, Tao
    MEDICAL SCIENCE MONITOR, 2019, 25 : 9517 - 9523
  • [5] PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ACUTE CORONARY SYNDROME
    Carter, Paul
    Baig, Mudassar
    Mavi, Jaskaran
    Ali, Noman
    Aziz, Amir
    Uppal, Hardeep
    Chandran, Suresh
    Sarma, Jaydeep
    Potluri, Rahul
    HEART, 2016, 102 : A15 - A16
  • [6] Hypertension or diabetes; which is worse prognostic factor for acute coronary syndrome patients following percutaneous coronary intervention?
    Kim, Y. H.
    Her, A. Y.
    Rha, S. W.
    Choi, B. G.
    Choi, S. Y.
    Byun, J. K.
    Choi, C. U.
    Kim, E. J.
    Park, C. G.
    Seo, H. S.
    Oh, D. J.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1400 - 1400
  • [7] Rehospitalization following percutaneous coronary intervention for commercially insured patients with acute coronary syndrome: a retrospective analysis
    Eric S Meadows
    Jay P Bae
    Anthony Zagar
    Tomoko Sugihara
    Krishnan Ramaswamy
    Rebecca McCracken
    Darell Heiselman
    BMC Research Notes, 5 (1)
  • [8] Safety and Effectiveness of Rivaroxaban in Patients with Acute Coronary Syndrome undergoing Percutaneous Coronary Intervention
    Li Xiaoyan
    Lu Ying
    Zhang Er Hong
    Zhang Ping
    Zhang Ping
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (16) : C150 - C150
  • [9] Feasibility and safety of noncontrast percutaneous coronary intervention in patients with complicated acute coronary syndrome
    Higuchi, Satoshi
    Kabeya, Yusuke
    Nishina, Yoshio
    Miura, Yusuke
    Yoshino, Hideaki
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2020, 96 (07) : E666 - E673
  • [10] Berberine ameliorates inflammation in patients with acute coronary syndrome following percutaneous coronary intervention
    Meng, Shu
    Wang, Lian-Sheng
    Huang, Zhou-Qing
    Zhou, Qing
    Sun, Ying-Gang
    Cao, Jia-Tian
    Li, Yi-Gang
    Wang, Chang-Qian
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2012, 39 (05) : 406 - 411